Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway
Abstract Background The present study aimed to evaluate the suppressive role of interleukin (IL)-25 in IL-22-induced osteoclastogenesis and receptor activator of nuclear factor κB ligand (RANKL) expression in rheumatoid arthritis (RA). Methods Serum from patients with RA and osteoarthritis (OA), and...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2020-09-01
|
| Schriftenreihe: | Arthritis Research & Therapy |
| Schlagworte: | |
| Online-Zugang: | http://link.springer.com/article/10.1186/s13075-020-02315-8 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
